Pharmaceutical firms rejected PM Peter Pellegrini’s demand to cut drug prices

15.11.2018

Pharmaceutical firms rejected PM Peter Pellegrini’s demand that they cut the prices of their drugs to the level in the three cheapest EU countries. The Slovak legislation has required this for seven years, but since the initial set-up, the state has not been checking the prices. If drug prices are cut, health insurers would save €50-70m annually. The legislation stipulates that the cheapest drug in a given group carry zero co-payment by patients. If the prices change, many patients would have to either switch to another drug or pay a higher co-payment. This would be unpopular, and the Health Ministry is yet to declare whether it will comply with the legislation and impose the price cuts.

 

(dennikN.sk)

Please reload

Táto správa je z Ekonomiky DNES, denného prehľadu najdôležitejších ekonomických správ zo Slovenska.

This news is from the Slovak Business News TODAY, one-page summary of all the important Slovak business news.

NBS warns about Novis

23.09.2020

The central bank NBS issued an injunction at the beginning of September banning Novis, an insurer, from selling investment insurance policies. It susp...

How will the wave of arrests end?

23.09.2020

Since the general election, the police have arrested 14 judges from Bratislava and Žilina, ex-Deputy Justice Minister Monika Jankovská, Marian Kočner,...

Aká bude koncovka súčasnej vlny zatýkania?

23.09.2020

Polícia od volieb zatkla 14 sudcov z Bratislavy a Žiliny, bývalú štátnu tajomníčku Ministerstva spravodlivosti Moniku Jankovskú, Mariana Kočnera, Norb...

1/5
Please reload

Copyright  © 1994 - 2019    Symsite Research         All rights reserved.